Reports for AA PHARMA INC
Company Name AA PHARMA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
446 |
|
| Actual shortage: | 21 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 419 (94%) | |
Discontinuation Reports |
63 |
|
| To be discontinued: | 9 (14%) | |
| Discontinued: | 52 (83%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
20 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2019-12-19 | 2020-03-04 | 101640 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2021-04-20 | 2021-06-24 | 137758 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2022-07-22 | 2022-08-25 | 165271 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2022-07-27 | 2022-08-25 | 165600 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-03-08 | 2023-06-13 | 186515 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-03-30 | 2023-06-13 | 188326 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-06-14 | 2023-10-04 | 194899 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-07-14 | 2023-10-04 | 198735 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-11-15 | 2024-01-31 | 210268 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2024-07-11 | 2024-08-16 | 232781 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-11 | 2024-08-06 | 221857 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2023-02-28 | 2023-05-01 | 185682 |
| LOVASTATIN | 40MG | TABLET | Resolved | 2025-03-19 | 2025-05-01 | 253032 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2021-07-08 | 2021-07-14 | 142026 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2023-11-15 | 2024-01-31 | 210273 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2024-07-31 | 2024-09-05 | 234154 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |